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Abstract
The study determined the effect of intravenous administration of acutely toxic or sub-lethal
doses of Na-oleate-coated Fe3O4 (OC-Fe3O4) nanoparticles (NPs) on liver structure and function
in Wistar rats, compared to titanium dioxide (TiO2) NPs and saline-injected controls. The acute
study, using a modified OECD 425 progressive dosing procedure, found LD50 values of 59.22
and 36.42mg/kg for TiO2 and OC-Fe3O4 NPs, respectively. In the sub-lethal study, rats were
either injected with saline (negative controls), a sub-lethal reference (0.592mg/kgTiO2 NPs,
equal to 1% of LD50 on a body weight basis) or OC-Fe3O4 NPs in doses equivalent to 0.1, 1 or
10% of the LD50, respectively (corresponding to 0.0364, 0.364 and 3.64mg Fe3O4/kg body
weight). Animals were sampled 24 h, 1, 2 and 4 weeks post-injection for adverse effects.
Mitochondrial respiration was significantly increased 2 weeks after injection of 10% OC-Fe3O4
NPs compared to controls, but the effect was transient. Cholesterol and triacylglycerol
concentrations in the liver tissue did not increase in any treatment. There were some
disturbances to antioxidant enzymes after OC-Fe3O4 NPs treatment in the livers of animals 1
week post-exposure; with the most sensitive changes occurring in glutathione peroxidase (GPx)
and glutathione S-transferase (GST) activities. Lipidosis and mild necrosis with changes in
sinusoid space were also observed in histological sections of the liver. Overall, these data
suggest that the liver likely retains functional integrity with acute and sub-lethal doses of
OC-Fe3O4 NPs, albeit with some stimulation of redox defences and evidence of some tissue
injury.
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Introduction
The present study reports some in vivo experiments conducted as
part of the NanoTest project (http://www.nanotest-fp7.eu/). The
main goal of the project was to develop alternative methods and
high-throughput testing strategies using in vitro and in silico
approaches to assess the toxicological profile of nanoparticles
(NPs) used in medical diagnostics. This requires validation by
collecting some in vivo data to compare with the in vitro and in
silico modelling (reported elsewhere in this volume). Na-oleate-
coated Fe3O4 (OC-Fe3O4) NPs were chosen for the present in vivo
study because toxicity of this NP was demonstrated during in vitro
experiments (Guadagnini et al. 2015). In keeping with the ethical
principles of reduction, refinement and replacement (the 3Rs), the
experimental design avoided conducting multiple toxicity tests
with iron (Fe) salts, where the iron-overload toxicity and
molecular biology of dissolved Fe is already well known (Aisen
et al. 2001; Eaton & Qian 2002). Instead, the design included
titanium dioxide (TiO2) NPs as a benchmark because this is a
more widely used NP where some information on systemic
toxicity and biochemical effects on the liver is known
(e.g. rodents; Wang et al. 2007; Umbreit et al. 2012; fish liver;
Federici et al. 2007), and a no added NP control (vehicle only). It
was not the purpose of this study to compare Fe NPs with
dissolved Fe metal salts, but instead to provide in vivo data to
support the replacement goals of the NanoTest project.
The present study used an intravenous (i.v.) route of exposure
to reflect the likely medical applications of Fe NPs in medical
imaging (Kim et al. 2001), where it is proposed that the NPs are
given as bolus injection into the vein of patients. NPs directly
injected into the blood for medical purposes are likely to end up in
the liver. The notion of first-pass metabolism by the liver is well
known. It has also been reported that, once inside the circulation,
NPs are recognised by macrophages and are phagocytosed
(Rømert et al. 1993; Sadauskas et al. 2007). Macrophages in
the liver constitute a major pool of the total number of
macrophages in the body. The Kupffer cells have been found to
be central to the clearance of circulating NPs from the blood and
their staggering ability to accumulate the circulating NPs has been
proved in several studies (Rømert et al. 1993; Sadauskas et al.
2007; Iversen et al. 2013).
Dissolved Fe is well known for its redox chemistry, catalysing
the Haber–Weiss reaction to generate superoxide inside cells, and
the dietary uptake of dissolved Fe also involves reductions of
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Fe(III) to Fe(II) by ferric reductase on the gut mucosa, with
subsequent reoxidation to Fe(III) on release into the blood (Bury
& Handy 2010). Fe overload in animals and humans is
characterised by oxidative damage to the liver (Eaton & Qian,
2002; Carriquiriborde et al. 2004), and this is a potential
theoretical concern for bolus injections of Fe NPs in human
patients. However, experimental trials with rodents so far suggest
that at least some forms of Fe NPs may be relatively inert, or at
least do not cause lasting haematological disturbances (Sebekova
et al. 2014; Iversen et al. 2013). However, the blood is only the
first line of redox defence and the effects on the liver cells that
form the central compartment for Fe metabolism need to be
investigated.
Mitochondria under normal conditions (not pathological) are
probably the most important cellular source of reactive oxygen
species (ROS) (Boveris & Chance 1973; Turrens 1997; Brookes
2004). The single-electron chemistry of mitochondrial oxidative
phosphorylation (ox-phos) generates ROS by default. These ROS
have roles in both physiological cell signalling and numerous
pathological situations. The primary ROS generated in the
organelle is superoxide (O2
), which is then converted to H2O2
by spontaneous dismutation, or by superoxide dismutase (SOD).
The primary factor governing mitochondrial ROS generation is
the redox state of the respiratory chain (Lambert & Brand 2004)
and the mild uncoupling of ox-phos, that is, proton (H+) leak
across the mitochondrial inner membrane (Brookes et al. 1998).
There is a positive correlation between H+ leak and lipid
polyunsaturation (Porter et al. 1996). It is possible that polyun-
saturated lipids per se modulate the activity of uncoupling
proteins or other proteins by affecting parameters such as
membrane fluidity. ROS-induced H+ leak via lipid oxidation is
also highly likely because superoxide preferentially oxidises
mitochondrial lipids, and lipid peroxides have well-established
effects on mitochondrial respiration (Cheremisina & Vladimirov
1975). Changes in the lipid storage pattern in the liver are also
readily discernible from routine histological sections
(Carriquiriborde et al. 2004). Mitochondrial function, oxidative
stress, lipid metabolism and storage are therefore part of a well-
known continuum that indicates adverse changes in the liver.
However, this fundamental aetiology of liver dysfunction has
never been demonstrated for a NP, and not for Fe NPs.
The aim of this work was, therefore, not only to provide the in
vivo data needed to help validate in vitro and in silico alternatives
to invasive toxicity tests but also to explore the effect of i.v.
administered TiO2 and OC-Fe3O4 NPs on liver mitochondria
respiratory function, on oxidative stress parameters and to
consider this in the context of possible histopathological changes
in the liver tissue.
Methodology
Nanoparticles
The NPs used in this study are commercially available and were
provided with physicochemical characterisation by the supplier,
while some further characteristics (e.g. the size distribution by
dynamic light scattering – NICOMP 370 submicron particle sizer,
DSS, California, USA; pH analyses) were performed on request
within the NanoTEST Consortium at the University of Venice
(Sebekova et al. 2014).
TiO2 NPs (P25 obtained from Evonik Degussa GmbH, Essen,
Germany); were provided by Joint Research Center (Ispra, Italy).
The following information was supplied with the dry powder:
nominal primary particle size 15–60 nm, crystal structure
reported as a mixture of anatase and rutile crystallites in a ratio
of 70:30 or 80:20), 4 99% purity, Brunauer–Emmett–Teller
(BET) surface area 61 m2/g. A stock solution was suspended in
physiological solution containing 10% v/v of rat serum (Sigma),
pH ¼ 7.5, and sonicated (DynatechArtek 300, Manassas, VA,
USA) for 15 min at 150 W in a tube with diameter of 9 mm. In this
suspension, the TiO2 NPs displayed bimodal size distribution,
with peaks at 84 ± 8 (61% of NPs) and 213 ± 15 nm (Sebekova
et al. 2014).
The OC-Fe3O4 NPs (7% v/v) were purchased from
PlasmaChem GmbH (Berlin, Germany) and supplied as a
dispersion with particles comprising 7% w/v; the shape of the
particles was oblong, crystal structure Spinel (octahedral), and the
surface was coated with oleate micelle. The particles had499%
purity, with an average iron oxide particle core size of 8 ± 3 nm,
hydrodynamic diameter of 14–15 nm (determined by dynamic
light scattering), and zeta potential of 30 mV at pH 7. The size
distribution for OC-Fe3O4 NPs was also bimodal, with peaks at 31
± 4 and 122 ± 3 nm, and pH of 6. After heating to 38C, the
planned volume was pipetted and diluted with physiological
solution. The sample was homogenised by manual shaking.
Acute toxicity study
The study was conducted according to the guidelines for
experimental studies using laboratory animals (86/609/EEC),
after the approval by the State Veterinary and Food Control
Agency in Bratislava (Slovakia). A total of 39 female outbred
Wistar rats (aged 8 weeks, weight 205.5 ± 8.5 g mean ± SD) from
Prague (VELAZ, s.r.o.) were used for the experiment. A total of
14 animals were used to establish the LD50 for TiO2 NPs, and 18
animals were used to test the LD50 for OC- Fe3O4 NPs. Seven
animals were removed from the experiment for different practical
reasons, for example, difficulty with injections where the NPs
were suspected to be injected paravenously or complications from
the xylazine anaesthesia. Rats were housed two animals per cage,
under constant room temperature and humidity, 12 h L:12 h D
light cycles, with ad libitum access to tap water and standard rat
chow (SP1, Top Dovo, Horne´ Dubove´, Slovakia). After a period
of resting and adapting to the husbandry conditions, NPs were
administered by i.v., under xylazine anaesthesia to the rodents.
The animals were monitored 1 h and 4 h after injection and every
24 h during the following 14 days. Each animal was individually
dosed, and therefore individually monitored during the experi-
ment. After death, the animals were carefully dissected to collect
the organs for routine wax histology, and samples were trans-
ported to the University of Plymouth for examination.
The acute lethal toxicity test was performed according to OECD
guidelines 425 (OECD 2008), except that i.v. administration was
used. The test consisted of a single ordered dose progression in
which animals were dosed, one at a time, at a minimum of 48 h
intervals. The first animal received a dose a step (3.2-fold) below
the level of the best estimate of the LD50. If the animal survived, the
dose for the next animal was increased by 3.2 times the original
dose; if it died, the dose for the next animal was decreased by a
similar dose progression. Each animal had to be observed for up to
48 h before making a decision on whether and how much to dose
the next animal. The rats were observed for mortality, body weight
effects and clinical signs for 14 days after dosing. A combination of
three stopping criteria were used (as describe in OECD 425; OECD
2008) to minimise the number of animals used for the test. Dosing
was stopped when one of these criteria was satisfied at which time
an estimate of the LD50 and a confidence interval were calculated
using the method of maximum likelihood for the test based on the
status of all the animals at termination.
Sub-lethal study design
The study was conducted according to the same ethical
approvals above. Female outbred Wistar rats (aged 8 weeks,
96 K. Volkovova et al. Nanotoxicology, 2015; 9(S1): 95–105
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weight 205.5 ± 8.5 g mean ± SD, n ¼ 160 rats) obtained from
Prague (VELAZ, s.r.o.) were used for the experiment. The
purpose of the current study was to determine the sub-lethal
effects of doses representing a fraction of the LD50 value. The
sub-lethal doses were calculated from the preliminary acute
experiment above. Female outbred Wistar rats (n ¼ 160 animals/
treatment) were randomly allocated into five groups consisting of
a negative control (saline vehicle only); a sub-lethal reference
dose (reference control) of a NP of known toxicity (0.592 mg/kg
TiO2 NPs, equal to 1% of LD50/kg body weight basis) and three
groups receiving OC-Fe3O4 NPs in doses equivalent to 0.1, 1 or
10% of the LD50, respectively (corresponding to 0.0364, 0.364
and 3.64 mg Fe3O4/kg body weight). Animals were then sampled
24 h after injection (1 day), 1, 2 and 4 weeks post-injection for
adverse effects. The i.v. injections (one injection per animal) were
performed under combined ketamine/xylazine anaesthetisation,
and on sampling days, animals were humanely euthanised by
exsanguination under ketamine/xylazine anaesthesia. Each treat-
ment consisted of 32 animals (n ¼ 4/time point), which were
blood sampled and dissected for the major internal organs (only
liver data are reported here). For biochemistry, fresh livers were
either used immediately or snap frozen in liquid nitrogen and
stored frozen at 80C.
Measurement of respiratory functions in isolated
mitochondria
Mitochondria were isolated from freshly excised livers by
differential centrifugation as described by Hogeboom (1955),
with some modification. The isolation medium was prepared,
according to Sammut et al. (1998), with the following modifica-
tion: it contained 225 mmol/l mannitol, 75 mmol/l sucrose and
0.2 mmol/l Titriplex III. The liver was minced in the isolation
medium (pH 7.4) at 4C and homogenised at a slow speed with
rests in ice between burst, using a teflon to glass homogeniser.
The homogenate was centrifuged at 700 g for 10 min to remove
debris, then the supernatant was decanted and centrifuged at 5600
g for 10 min. The mitochondrial pellet was washed twice with
isolation medium. The resulting pellet was then resuspended in
the same medium to a final protein concentration of 20–40 mg/ml.
All procedures were performed at 4C. Protein concentration in
the washed mitochondria was determined, according to Lowry et
al. (1951).
Respiratory function of mitochondria was determined using
the voltamperometric method on an Oxygraph Gilson 5/6 H
instrument (Gilson Medical Electronics Inc., Middleton, WI,
USA) with the use of Clark oxygen electrode (Yellow Springs
Instruments Co., Yellow Springs, OH, USA) at 30C. The
incubation medium was prepared as described by Rouslin &
Millard (1980) with a modification: 12.5 mmol/l HEPES,
122 mmol/l KCl, 3 mmol/l KH2PO4, 0.5 mmol/l Titriplex III and
2% dextran. Glutamate/malate at 2.5 mmol/l concentration for
both was used as substrate for nicotinamide adenine dinucleotide
(NAD). For assessing stimulated oxygen consumption, 500 nmol
of adenosine diphosphate (ADP) was added.
The following parameters were determined in the liver
mitochondria: oxygen consumption after stimulation by ADP
(QO2(S3)) expressing the velocity of oxygen consumption by
mitochondria in the presence of ADP and substrate; the rate of
basal oxygen uptake by mitochondria without ADP – state 4
(QO2(S4)) denotes how fast oxygen is used by mitochondria in
the presence of substrate only and the rate of ox-phos (OPR)
(rate of adenosine triphosphate [ATP] production). Subsequently,
the Respiratory Control Index (the ratio of state 3 to state 4)
was calculated as an indicator of mitochondrial membrane
integrity. Similarly, the coefficient of ox-phos (ADP:O) was
calculated as an indicator of coupling of oxidation with
phosphorylation.
Biochemical analysis of liver homogenates
The potential for NPs to cause oxidative stress in the liver was
evaluated by several biochemical approaches. These included
determination of lipids that might be sensitive to oxidative stress
(cholesterol and triacylglycerol) as well as reduced and oxidised
forms of co-enzyme Q (CoQ). In addition, antioxidant enzyme
activities and the malondialdehyde (MDA) product of lipid
peroxidation were also measured in liver homogenates.
Triglyceride concentrations in the liver were determined by the
modified method of Jover (1963). Liver tissue (100 mg) was
homogenised and extracted in chloroform–methanol (2:1). The
interfering phospholipids were removed by absorption from the
liver extract on silica gel. Purified extracts were evaporated and
triglycerides were hydrolyzed with potassium hydroxide.
Released fatty acids were removed by extraction into heptane.
Finally, the released glycerol was oxidised by periodic acid, and
after the reaction with phenylhydrazine hydrochloride and potas-
sium ferricyanide, a coloured complex was spectrophotometric-
ally measured at 530 nm.
Cholesterol was determined by the modified method of Abell
et al. (1952). Liver tissue (100 mg) was homogenised in
chloroform–methanol mixture (1:1). After lipid extraction, the
Liebermann–Burchard colorimetric assay was used for the
detection of cholesterol. Cholesterol concentrations were spec-
trophotometrically determined at 650 nm.
Oxidised and reduced forms of CoQ (CoQ9-ox and CoQ9-red)
were measured by a high-performance liquid chromatography
(HPLC) method with spectrophotometric detection (Lang et al.
1986). The liver tissue (100 mg) was homogenised using an
Ultra-Turrax in 1 ml of redistilled water with an addition of 50 ml
of butylhydroxytoluene (BHT, 10 mg/L ml of 99.9% ethanol). The
homogenate was extracted by hexane–ethanol mixture (5/2, v/v)
with an addition of 1 ml of 0.1 M sodium dodecyl sulphate for 5
min. Liver mitochondrial suspension (100 ml) was extracted with
an addition of 20 ml of BHT. The collected organic layers were
evaporated under nitrogen (Termovap, 50C) and the residues
taken up in ethanol and injected to the HPLC column SGX C18,
7 mm (Tessek Ltd, Czech Republic). The mobile phase consisted
of methanol/acetonitril/ethanol (6/2/2, v/v/v, Merck, Germany).
The concentrations of compounds were spectrophotometrically
detected using external standards (Sigma, Germany): tocopherols
at 295 nm and CoQ at 275 nm. Data were collected and processed
using CSW32 chromatographic station (DataApex Ltd, Czech
Republic).
An aqueous phase buffer was used for the preparation of liver
homogenates for antioxidant enzymes and MDA determination.
Briefly, 100 mg of frozen liver tissue was homogenised in 1 ml of
ice cold distilled water (10% w/v) using an Ultra-Turrax T8
homogeniser (IKA Labortechnik), set at 5000/min for 3 times 10
sec. The crude homogenate was centrifuged (1000 g) at 4C for 10
min to remove debris, and the resulting supernatant diluted to
0.01% w/v of the original liver weight. Activity of glutathione
peroxidase (GPx) was determined by a kinetic method, according
to Paglia & Valentine (1967); the method is based on the ability of
GPx to catalyze the oxidation of reduced glutathione (GSH) into
oxidized glutathione (GSSG). The amount of GSSG is measured
using glutathione reductase, and the reaction involves using
nicotinamide adenine dinucleotide phosphate (NADPH). The
amount of consumed NADPH is detected as a decrease of
absorbance at 340 nm.
The activity of glutathione S-transferase (GST) was assessed
by a kinetic method, according to Habig et al. (1974); the reaction
DOI: 10.3109/17435390.2013.815285 In vivo study of liver 97
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mixture contained 0.1 mol/l potassium phosphate buffer and 0.1
mol/l reduced glutathione. 1-chloro-2,4-dinitrobenzene was used
as substrate (10 mmol/l). To minimise any non-enzymatic reac-
tion, the measurements were conducted at 25C and pH 6.5. The
difference in absorbance was measured at 340 nm before and after
the total enzymatic change of the substrate into product.
Concentration was calculated from millimolar extinction coeffi-
cient for 1-chloro-2,4-dinitrobenzene conjugate at 340 nm (9.6).
The activity of SOD was estimated by a commercial test kit
(Randox Lab. Ltd, Grumlin, UK). The method employs xanthine
and xanthine oxidase to generate superoxide radicals which react
with 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium
chloride (I.N.T.) to form a red formazan dye. The SOD activity
is then measured by the degree of inhibition of this reaction. One
unit of SOD causes a 50% inhibition of the rate of reduction of
I.N.T. under the conditions of the assay. Catalase (CAT) activity
was spectrophotometrically measured by a modified method of
Cavarocchi et al. (1986). Briefly, the sample (50 ml of 1000 times
diluted homogenate) was incubated for 10 min at 25C with 0.01
mol/l potassium phosphate buffer, pH 7.8, which contained the
substrate (0.285 mmol/l H2O2). Concentration of the remaining
substrate in the reaction mixture was assessed at 505 nm by using
the mixture for determination of H2O2. This mixture contained
3 mmol/l 4-aminoantipyrine, 0,1% water solution of phenol and
10 ml of peroxidase (2500 U/ml). Concentration of the remaining
substrate was calculated from calibration curve.
Lipid peroxidation was assessed by measuring the concentra-
tion of MDA in the homogenates using a modified HPLC method
(Wong et al. 1987), which involved first conjugating MDA with
thiobarbituric acid (TBA), isolation of the MDA–TBA adduct by
HPLC and detection by fluorimetry. Briefly, 50 ml of the aqueous
supernatant above was added to a glass tube containing 750 ml of
0.44 mol/l phosphoric acid, 250 ml of 4.42 mmol/l TBA solution
and 450 ml distilled water. After vortexing, the solution was
incubated in a water bath at 100C for 1 h, then cooled on ice. The
MDA–TBA adduct was stable in the acidic pH of the media.
Then, 500 ml of each sample was added into a tube containing
500 ml of methanol–NaOH solution (1 mol/l). The resulting
mixture was then briefly vortexed and then centrifuged (11,300 g)
for 3 min. HPLC was performed by adding 50 ml of the resulting
supernatant to a Lichrospher 100 RP-18 column (125  4 mm
I.D., 5 mm, Merck). The mobile phase consisted of potassium
phosphate buffer (50 mmol/l, pH 6.8) and analytical grade
methanol (60/40, v/v – mixture ratio of phosphate buffer and
methanol). The TBA–MDA adduct was monitored by fluores-
cence (excitation wavelength, 532 nm; emission wavelength,
553 nm) on a Jasco 920 detector.
Liver histology
Histological examinations were performed as described in Al-
Bairuty et al. (2013), with minor modifications. Livers were
examined from both the acute and sub-lethal experiments. For the
acute lethal experiment, livers were collected after each animal
was sacrificed at the appropriate time point. For the sub-lethal
study, livers were collected for histology at each time point (5–8
livers from each treatment/time point). Livers were fixed for at
least 2 weeks in buffered formal saline (250 ml 40% formalde-
hyde, 10 g NaH2PO4.1 H2O, 16.5 g NaH2PO4 (anhydrous), diluted
to 2.5 L with distilled water and buffered to pH 7.2). Tissues were
processed into wax blocks, and transverse sections (7–8 mm
sections) were cut from each animal. Slides were stained with
Mallory’s trichrome. Photographs were taken using an Olympus
Vanox – T microscope connected to an Olympus digital camera
(C-2020 Z). Subsets of slides were independently scored to check
for observer bias (this was negligible). Slides were also processed
in batches containing controls and treatments were conducted to
eliminate staining artefacts (SAs). Quantitative histological
measurements were made. Fractional areas of the proportions of
hepatocytes area and sinusoid space in the liver tissues were
manually counted from a randomly selected area on a section
from each animal (image) using the point counting method of
Weibel et al. (1966), where the fractional volume (area) Vi ¼ Pi/
PT and Pi is the number of points counted, PT is the total number
of points on the counting grid.
Statistical analysis
For the acute study, software AOT 425 StatPgm (http://
www.epa.gov/oppfead1/harmonization) was used for the progres-
sive calculation of the median lethal dose and to inform on the
stop criteria in each acute toxicity test. Curve fitting of injected
dose with survival time was performed using SigmaPlot version
12.2. Data from quantitative histology were not statistically
analysed as the OECD 405 test design has insufficient replicates
at each dose to conduct any useful analysis.
For the sub-lethal experiment, SPSS version 13.0 (SPSS Inc.,
Chicago, IL, USA) software was used for statistical analysis of all
biochemistry and mitochondrial function data. Independent
samples (unpaired) student’s t-test was used to test for significant
differences for normally distributed data, Mann–Whitney U test
for not-normally distributed data. Differences with p50.05 were
considered to be statistically significant. Data from quantitative
histology were analysed using StatGraphic Plus version 5.1. One
way analysis of variance (ANOVA) was used to identify dose–
effects within the Fe NP treatments. The least squares difference
post hoc test was used to identify differences between doses or
between time-effects, where appropriate. Bartlett’s test was used
to check the validity of each ANOVA. In addition, two-way
ANOVA was used to check for treatment  time effects in the
data. The student’s t-test was also sometimes used to investigate
the differences between the pairs of data, where appropriate, such
as comparing the 1% reference TiO2 treatment with the equivalent
OC-Fe3O4 NP treatment. For multiple comparisons with non-
parametric data, the Kruskal–Wallis test was used for data that
could not be transformed or the non-parametric Mann–Whitney U
test was used as appropriate for pairs of data. All statistical
analysis used the default 5% rejection level.
Results
Acute study
After single i.v. injection to adult rats, the LD50 for TiO2 NPs was
established to be 59.22 mg/kg with a confidence interval from 55
to 70 mg/kg. For OC-Fe3O4 NPs, the LD50 was 36.42 mg/kg with
a confidence interval (0–20,000 mg/kg). The end of the experi-
ment was also predicted by the software, when at dose 44 mg/kg,
one animal survived and two died and at dose 35 mg/kg one
animal survived and one died. Experimental modelling showed
that continuing the study with additional animals would not
improve the robustness of the statistical significance. The
relationship between injected dose and the time of survival is
shown (Figure 1) for animals that died within 2-week observation
period. In general, the expected trend of decreasing survival time
with increasing dose was observed. However, there was some
inter-animal variability. For example, one animal injected with
139 mg/kg TiO2 NPs survived until the end of the experiment
(still alive at week 2 or 336 h post-injection), while another
animal injected with the same dose survived only 10 h. Both
animals injected with 55 mg/kg TiO2 survived suggesting the
acute toxicity threshold was somewhere between this dose and the
next highest used (70 mg/kg). For OC-Fe3O4 NPs, two out of four
98 K. Volkovova et al. Nanotoxicology, 2015; 9(S1): 95–105
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animals injected with 44 mg/kg survived, and one of two animals
injected with 35 mg/kg survived, while the other died at 10 h post-
injection.
The cause of death was not acute liver injury as the livers from
the animals showed only mild or more moderate diffuse necrosis
and some mild evidence of lipidosis, with some areas of normal
cells (Figure 2). Blood vessels (BVs) and sinusoids were generally
intact in all the animals examined and, for example, perivenular
bleeding was not observed. There were no obvious signs of
treatment-dependent changes in the proportional area of sinusoid
space (ranging from 6 to 14% across all the animals examined).
However, the red cells in the sinusoids were eosinophilic, and this
was different from the occasional SA (condensed haematoxylin,
not in the sinusoids) observed in one animal from the 139 mg/kg
TiO2 injection. Notably, granular deposits were observed in
macrophages in the sinusoids, being present in the livers of all the
animals examined that died regardless of the type of nanomaterial
injected, but was much less evident or absent in the animals
surviving the 55 mg/kg TiO2 treatment.
Sub-lethal injection study
There were no treatment-dependent mortalities in the sub-lethal
study, although a range of biological effects were observed.
Mitochondrial functions
Single i.v. administration of either type of NP or the vehicle
controls had no statistically significant effect on ADP-stimulated
respiration rate (QO2 (S3)) 24 h after the injection (p40.05) with
values ranging from 100.65 ± 10.07 (control), 96.57 ± 4.45 (1%
reference dose TiO2), and 99.62 ± 6.43 to 109.05 ± 7.99nAtO.mg
prot.1.min1 for the lowest to highest OC-Fe3O4 NP treatments.
However, there was a transient increase in the ADP-stimulated
respiration rate to 134.97 ± 5.19nAtO.mg prot.1.min1 at week
2 in the highest OC-Fe3O4 NP treatment (statistically significant
increase relative to controls, p ¼ 0.007), but this difference was
lost by the end of the experiment (week 4) with values returning
to control levels (data not shown). Similarly, there were only
minor changes in the basal respiration rate (QO2 (S4)), with a
transient but statistically significant increase (p ¼ 0.02) to 14.86
± 0.99nAtO.mg prot.1.min1 in the 10% equivalent dose of OC-
Fe3O4 NP treatment from the control value of 11.07 ± 1.04
nAtO.mg prot.1.min1 at week 2 but with this difference being
lost by week 4 (data not shown). OPR also showed a transient rise
in the same treatment at the same time point (p ¼ 0.014) –
increasing to 368.73 ± 14.95 from the control value of 298.50 ±
19.63 nmolATP.mg prot.1. min1 at week 2. No other significant
differences in OPR were observed (data not shown). No
significant differences were detected in the calculated coefficient
of ox-phos, which is indicator of coupling of oxidation with
phosphorylation or in S3:S4 ratio – a parameter of mitochondrial
membrane integrity was detected between the groups at any time
interval after exposure. They were in the range between 8.38 ±
0.52 and 10.18 ± 0.40. There were no changes in the concen-
trations of the oxidised form of CoQ10 in isolated liver
mitochondria during the experiment (data not shown), except at
week 4 post-injection, where the concentration was significantly
lower (p ¼ 0.049) in the 0.1% equivalent dose of OC-Fe3O4 NPs
at 4 weeks, with the value decreasing to 4.65 ± 2.83 nmol/mg
protein compared to the control (6.73 ± 2.65 nmol/mg protein).
No significant differences in oxidised or reduced forms of CoQ9
in isolated liver mitochondria were recorded between the groups
at any other time interval after exposure.
There were no significant differences in cholesterol or
triacylglycerol (TAG) concentrations in the liver tissue between
the groups (data not shown).
There were no clear time- or treatment-dependent effects on
the activities of GPx or GST (Figures 3A and B), except for a
transient change in the liver homogenates at 1 week post-exposure
where GPx activity was significantly lower (p ¼ 0.044) and the
activity of GST was significantly higher (p ¼ 0.040) in the group
with the highest concentration of OC-Fe3O4 NPs compared to
controls. Similarly, there were no clear time- or treatment-
dependent changes in the MDA concentrations in liver homogen-
ates (Figure 3C). However, there was a statistically significant
decrease in MDA concentrations at day 1 post-exposure in the
group with the lowest concentration of OC-Fe3O4 NPs compared
to controls (Figure 3C). There were no significant differences in
the activities of SOD and CAT in liver tissue homogenates
between the groups at any time interval after exposure to NPs.
SOD activity was the highest in the group with 1% OC-Fe3O4 NPs
compared to controls (4.140 ± 0.837 vs. 3.318 ± 0.349 mmol/min/
mg protein) 1 day post-exposure. Activity of CAT was the highest
in the group with the lowest concentration of OC-Fe3O4 NPs
compared to controls (16.13 ± 1.41 vs. 14.70 ± 2.25 mmol/min/
mg protein).
Liver histology following sub-lethal injections
Example images of the livers from rats at day 1 post-injection are
shown in Figure 4. Overall, the unexposed controls were normal,
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Figure 1. Relationship between dose and survival time in rats that were
i.v. injected with a single acute treatment of (A) TiO2 NPs or (B)
OC-Fe3O4 NPs. Each data point is a single animal and curves were fitted
using SigmaPlot 12.2 to an inverse first order polynomial fit. For TiO2
NPs: y ¼ 74.0 + (252.2/x), r2 ¼ 0.26, n ¼ 6 rats. For OC-Fe3O4 NPs: y ¼
0.51 + (981.9/x), r2 ¼ 0.49, n ¼ 10 rats. Some animals that survived for
2 weeks and were subsequently euthanised for histology are not included
in the curve fits.
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but there were some minor injuries associated with both types of
NPs, which improved over time. The livers of control animals at
day 1 post-injection showed normal histology (all five animals
examined) with well-defined nuclear membranes, a condensed
nucleolus and with normal granular diffuse chromatin.
Hepatocytes showed apparent glycogen storage space, although
the livers were lean (as expected from young rats on maintenance
rations). The sinusoid space appeared normal, and BVs where
observed showed a normal endothelium. There was no evidence
of perivenular bleeding, fatty change, extensive intracellular
lipidosis or vacuoles in the parenchyma. Controls examined at
week 1 through to week 4 showed similar normal architecture.
The TiO2 treatment caused some minor pathology, which
improved slowly but had not fully recovered by 4 weeks post-
injection. At day 1 post-injection, six of seven of the specimens
examined showed evidence of either diffuse definition of some of
the cell membranes and some slight loss of definition to the
nucleus, indicating a mild diffuse necrosis. In addition, four of
seven livers showed some mild lipidosis and the occasional
vacuole formation in cells. This was only evident in livers with
apparent glycogen space, and lean livers (three of seven livers)
showed no lipidosis. Where BVs were observed, the endothelium
was intact. The mild necrosis (four of seven animals) continued by
week 1 post-exposure and was still mildly present at week 4 (all
six animals examined), with four of six animals examined
showing some residual lipidosis.
Overall, the exposure to OC-Fe3O4 NPs caused the most liver
pathology at day 1 post-exposure, and there was a clear dose-
dependent increase in the injuries with generally mild effects at
the 0.1% equivalent dose compared to the occasional area with
Figure 2. Examples of liver histology from
the acute study with rats injected with (A)
220 mg/kg OC-Fe3O4 NPs and surviving for
about 5 min, (B) 110 mg/kg OC-Fe3O4 NPs
and surviving for 11 h, (C) 139 mg/kg TiO2
NPs and surviving for 10 h, (D) 55 mg/kg
TiO2 and still alive at the end of the
experiment (2 weeks post-injection). Note
that the mild and diffuse necrosis in all the
specimens, evidence of lipidosis in a few
cells (black arrows) and granular deposits
(assumed hemosiderin deposits) in macro-
phages (white arrows) are located mainly in
the sinusoid space (S). Note the occasional
SA and more basophilic nature of the staining
with the higher TiO2 NP injection, and the
intact BV with endothelium at the lower TiO2
dose. Sections (7–8 mm) were stained with
Mallory’s trichrome.
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Figure 3. The effect a single sub-lethal i.v. injection of OC-Fe3O4 NPs on (A) GPx activity, (B) GST activity and (C) MDA concentrations in liver
homogenates. Livers were collected at day 1 and 1, 2 and 4 weeks post-injection for biochemistry. Data are means ± S.D., n ¼ 8 rats/treatment at each
time point; *statistically significant difference from the control within treatment and time point.
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moderate or worse loss of liver architecture in the 10% equivalent
dose of the Fe NPs. However, the injuries showed some
improvement by week 1 and in most cases completely recovered
by week 4. At day 1 in the 0.1% equivalent dose of OC- Fe3O4
NPs, six of eight livers examined showed a mild or moderate
diffuse necrosis. In all the livers with apparent glycogen space,
there was also a mild lipidosis (three of eight animals). The
animals from the 1% equivalent dose showed a greater incidence
of necrosis (six of seven showing moderate areas of necrosis), and
four of seven showed lipidosis that was worse than the 0.1% Fe-
NP treatment. The pathology was greatest at day 1 in the highest
Fe concentration. The livers of two of five animals examined
showed a diffuse loss of architecture (wide-spread but moderate
necrosis) with lipidosis. In the remaining three of five livers, the
damage was slightly more severe. A quantitative analysis of the
proportional of sinusoid space in the livers at day 1 post-injection
showed that the sinusoid space had significantly increased
(ANOVA, p ¼ 0.0045) in the 0.1% and 10% equivalent dose of
OC-Fe3O4 NPs compared to controls, with the highest Fe
treatment showing the greatest increase in sinusoid space
(Figure 4).
By week 1 post-injection, the livers from the 0.1% equivalent
dose of Fe-NPs continued to show necrosis (all seven animals)
and three animals also showed mild-to-moderate lipidosis.
However, by week 2, this had improved and at week 4 only two
of seven animals had a mild diffuse necrosis and five of seven
were normal compared to time-matched controls. In the 1%
equivalent dose at week 1, three of six animals showed moderate
necrosis with lipidosis (three were normal), but this also improved
over time with five of six animals examined being normal at week
2 and week 4. In the 10% equivalent dose mg/kg treatment, the
pathology had improved compared to the animals at day 1, with
all four specimens examined showing diffuse mild or moderate
necrosis. In these animals, sinusoid space was discernible and
BVs were intact. By week 4, the animals had recovered, with all
five animals examined at the highest Fe NP concentration having
normal histology.
Discussion
This study provides one of the first detailed insights into the sub-
lethal effects of known doses of OC-Fe3O4 NPs relative to the
lethal concentration and compared to a reference dose of TiO2
NPs. Overall, the data show that there are transient disturbances to
enzymes involved in redox defences (GPx and GST) in the first
week following sub-lethal injection, then later in week 2, some
transient increases were detected in mitochondrial respiration
(basal oxygen consumption and the OPRs) in the OC-Fe3O4 NPs
group, without changes in cholesterol or triacylglycerol concen-
trations. The liver histology revealed some mild lipidosis due to
TiO2 NPs one day after injection, and progressive (dose-
dependent) lipidosis with diffuse necrosis in the livers from the
Figure 4. Histological sections of rat liver 1
day after a single sub-lethal i.v. injection of
OC-Fe3O4 NPs. (A) control (vehicle only),
(B) a reference TiO2 NP dose equivalent to
1% of the LD50 and doses of OC-Fe3O4 NPs
equivalent to (C) 0.1%, (D) 1% and (E) 10%
of the LD50. Note the normal morphology of
the controls, but more diffuse morphology
and early signs of mild lipidosis (black
arrows) in the TiO2 treatment, but normal
endothelium (white arrow) of the BV and
sinusoid space (S). The lipidosis and diffuse
mild-to-moderate necrosis progressed with
increasing doses of the OC-Fe3O4 NPs. Panel
(F) shows the proportion of sinusoid space in
each treatment at day 1. Data are means ±
S.D. n ¼ 5–8 rats/treatment; *statistically
significant difference from the control
(ANOVA, p50.05); #statistically significant
difference to the other Fe NP treatments.
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OC-Fe3O4 NPs groups, but the livers showed recovery in most
treatments by week 4 post-injection.
Progressive dose method for the determination of acute
toxicity
The OECD guideline 425 is an acute oral toxicity test (via oral
gavage) that uses a progressive single dosing procedure to
minimise the use of animals, while enabling an estimation of the
median lethal concentration. In the present study, the design of the
OCED 425 test had been followed, except that i.v. injection rather
than oral gavage had been used to reflect the clinical application
of the nanomaterials. The data analysis shows that this procedure
will give lethal dose estimates, and the method gives the expected
trend of increasing survival at the lower doses for both materials
(Figure 1). This suggests that an i.v. modification of the OECD
425 test may be suitable for the acute testing of nanomaterials.
Similar to our approach, Gajdosikova et al. (2006) also used this
guideline for determining the LD50 for i.v. administered Fe3O4
NPs in mice, finding an LD50 in the range of 231–559 mg/kg of
body weight, depending on the type of coating on the material.
The LD50 in the present study (36 mg/kg for OC-Fe3O4 NPs) is a
little less for rats, and may be due to species difference, although
the confidence intervals in both studies overlap.
One major concern of the progressive dose method is that the
confidence intervals calculated by the software are not exact, and
with typically low number of animals used in an acute test, the
method should only be considered as a guide to indicate a range
where the LD50 may be found (OECD 2008). In cases, such as the
TiO2 experiment, where there was a clear dose where all the
animals died and the next lowest dose where all the animals
survived, the software will tend to generate reasonably tight
confidence intervals (55–70 mg/kg in the present study for TiO2
NPs). However in the OC-Fe3O4 NPs experiment, the confidence
interval was very large (0–20,000 mg/kg) and this is related to a
limitation of the computation method used in the OECD 425 test.
At the two lowest doses used, some animals survived, but at the
same doses some animals died. This uncertainty, while still
meeting the stop criteria of the test, leads to an artefact in the
confidence interval where the lower confidence interval is
estimated at infinity (i.e. reported as zero) and often with a
high upper confidence interval as well. This is a generic limitation
of the test procedure and is recognised in the guidance notes
(OECD 2008). It can be mathematically overcome by increasing
the number of animals above and below the threshold for toxicity,
but this solution would be in direct conflict with the original
ethical drivers of minimising the use of animals that the test was
designed to achieve. In the case of the present study for OC-Fe3O4
NPs, this problem relates only to identifying the outer limits of the
confidence interval for all the data and does not mean the
resulting LD50 is of no scientific value; the software will still
produce a lethality estimate around the median. However, the data
should be interpreted with caution.
The results of the acute toxicity test also identified some inter-
animal variability in mortality time that was not always explained
by the exposure dose. During the study, several practical
difficulties were encountered. At relatively high doses (close to
the lethal dose), animals had to be injected with volumes often
exceeding 0.5 ml, although this remained 55% of the blood
volume (estimated blood volume of a 205 g rat is 11.9 ml), the
procedure lasted more than 10 sec, so it was necessary to keep the
animal under anaesthesia during the tail vein injection. Some
necrosis/injury of peripheral tissue in the distal part of tail after
injection did emerge after several days, suggesting some collapse
or thrombosis of the BVs distally to the site of injection with high
doses. However, this was a localised effect as internal organs,
such as the liver, showed normal vasculature and sinusoid space
(Figure 2).
The cause of death in the animals from the acute study cannot
be deduced from the time to mortality measurements made in this
modified version of the OECD 425 test. However, the absence of
gross pathology in the livers, with generally normal sinusoids,
only mild diffuse necrosis, and evidence of macrophage activity,
suggests that liver failure is an extremely unlikely explanation.
Sub-lethal effects of the TiO2 NP reference dose
The study design of the sub-lethal experiment incorporated a
reference dose of TiO2 NPs equivalent to 1% of the lethal dose (an
actual dose of 0.592 mg/kg TiO2 NPs). Acute studies with i.v.
injections of at least ten times the dose used here in rodents (e.g.
van Ravenzwaay et al. 2009, 5 mg/kg body weight) show that
systemically available TiO2 NPs are mainly trapped in the liver
(and spleen), thus confirming the importance of the liver as a
target organ for i.v. injections. Similar observations have been
made in fish injected with TiO2 NPs with a trend of increasing Ti
metal in the liver (Scown et al. 2009). The single i.v. adminis-
tration of TiO2 NPs did not induce any significant change in the
parameters measured in the present study. Recently, Umbreit et al.
(2012) injected mice with 56 mg/kg TiO2 NPs and reported no
major histological changes in the liver, apart from an expected
macrophage infiltrate to deal with the NPs deposited in the tissue.
Similarly, this study found relatively modest changes in liver
histology with a TiO2 injection (Figure 4), and with no
statistically significant change in sinusoid space indicating that
blood flow and/or fluid balance in the liver was also unaffected.
Thus, overall, the reference TiO2 dose behaved as expected and
had no or limited effects on the parameters measured.
Effects of OC-Fe3O4 NPs
The present study showed some transient effects of mitochondrial
respiration, and there are some relatively well-known mechanisms
for the effects of traditional dissolved forms of metals on the
functions of mitochondria. These can include: (i) indirect effects
through systemic hypoxia caused by respiratory injury or
disturbances to the cardiovascular system (Watts et al. 1999)
and (ii) direct interference of the dissolved toxic metal with
respiratory coupling in the mitochondrial respiratory chain or the
metal centres in the enzymes involved in the chain (e.g. Belyaeva
& Korotkov 2003). In the present study, systemic hypoxia seems
unlikely because the animals were not exposed via the lung. In
addition, a previous report of blood function in the same animals
used here showed no adverse effects on haematology or total
concentrations of plasma Fe (Sebekova et al. 2014), although,
injections of high doses of Fe NPs can produce a transient drop in
mean arterial blood pressure in rats (10 mg/kg, Iversen et al.
2013). Respiratory chain uncoupling also seems unlikely since the
homogenates demonstrated ADP-dependent stimulation of respir-
ation and respiration rates did not decrease. Direct interference of
dissolved Fe with copper (Cu) centres in enzymes such as SOD
(Moody 1997) also seems unlikely, given that in dissolved iron
toxicity the Cu is not displaced, and in the nano form, the
dissolution rates of dissolved Fe from Fe3O4 NP are low
(Sebekova et al. 2014). In addition, in vitro studies with Fe3O4
NPs (30–45 nm) on the neuro-2A cell line did not demonstrate a
decrease in mitochondrial function (Jeng & Swanson 2006), thus
supporting the findings here in vivo. Instead, the increase in
oxygen consumption after stimulation by ADP, basal oxygen
consumption and OPR (rate of ATP production) at week 2 is
interpreted as a transient adaptive change to maintain mitochon-
drial respiration, following a brief period of mild oxidative stress
the week before (see below). CoQ plays an important role in
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mitochondrial bioenergetics in both the electron transport chain
and proton translocation in order to power the proton motive
gradient necessary for ATP synthesis (Villalba et al. 1995;
Bhagavan & Chopra 2006). The CoQ9 homologue is the dominant
form of CoQ in rats. No significant differences in oxidised or
reduced forms of CoQ9 in isolated liver mitochondria were
detected in this study, confirming that homeostasis was main-
tained. However, concentrations of the oxidised form of CoQ10 in
isolated liver mitochondria were significantly lower in the group
with the lowest dose of OC-Fe3O4 NPs 4 weeks after exposure.
This decrease was only of about 2 nmol/mg protein, and the
reported CoQ10 value of 4.65 nmol/mg protein was within the
normal range expected in rat liver homogenates (e.g. about 1
nmol/mg protein, Kwong et al. 2002). This small change might be
explained by increased activity of the Fe-dependent NADH CoQ
reductase which replenishes the supply of the reduced form of
CoQ; however, further experiments are needed to verify this
suggestion.
Some metallic NPs are now known to cause oxidative stress
(Schrand et al. 2010), and this has also been suggested as a mode of
action for iron oxide NPs (in hepatocytes, Hussain et al. 2005; lung
epithelial cells, Khan et al. 2012). The i.v. injections of Fe
complexes affect the extent of weakly bound iron and thus the
degree of oxidative stress. Toblli et al. (2011) showed that low
molecular weight iron dextran and ferumoxytol caused renal and
hepatic damage in normal rats, which was demonstrated by
proteinuria and increased liver enzyme activities. Oxidative stress
in these tissues was also implicated by higher MDA concentrations,
increased antioxidant enzyme activities and a significant reduction
in the reduced glutathione to oxidised glutathione ratio (Toblli et al.
2011). Similarly, Feng et al. (2011) found alterations of renal,
hepatic and spleen functions, which were reflected by changes in a
number of metabolic pathways including those involved in energy,
lipid, glucose and amino acid metabolism after i.v. administration
(25 mmol/l iron suspended in 0.9% saline) of ultra-small super-
paramagnetic particles of iron oxide. The present study, at much
lower injected doses than those studies above, did not show any
statistically significant changes in the MDA concentrations in the
liver homogenates, but did show a transient increase of GST
activity 1 week after the injection of OC-Fe3O4 NPs. GSTs carry
out a wide range of functions in cells, including the removal of ROS
during oxidative stress (Feng et al. 2011), the conjugation of
reduced glutathione to electrophilic centres in Phase II reactions
(Habig et al. 1974) and the reaction with numerous exogenous
chemicals including environmental pollutants and oxidised bio-
molecules (Hayes & Pulford 1995). It is, therefore, not possible to
specifically identify the specific mechanism of the GST increase in
this study, but some oxidative stress seems likely, given the mild
lipidosis in the livers (caused by lipid peroxidation).
A statistically significant decrease in the activity of GPx was
also detected 1 week after the injection and was coincident
with the liver pathology (Figure 4). GPx has roles in the
detoxification of H2O2 (likely produced from hydroxyl radicals in
Haber–Weiss reaction), and GPx activity is, therefore, expected to
increase during ROS production. However, GPx activity is
dynamic, and chemical antioxidants are regarded as the first
line of defence inside the liver in vivo (vitamin E levels,
glutathione concentrations). The absence of increases in MDA in
the present study suggests that upregulation of GPx activity was
not needed.
Liver pathology from Fe overload is well known and involves
oxidative damage to the liver that may manifest as fatty change,
leading to lipidosis (peroxidation of lipids in the tissue) and
eventually to necrosis of the liver cells (Whittaker et al. 1996;
Carriquiriborde et al. 2004). Ma et al. (2012) reported that the
liver cells ‘‘expanded’’ and the liver sinus contracted with an
intraperitoneal dose of 10 mg/kg of Fe3O4 NPs and found
glutathione depletion in liver homogenates at doses of 40 mg/kg
of the material. Unfortunately, Ma et al. (2012) did not perform
quantitative histological measurements or use proper technical
terms to describe the histology. They also reported a euthanasia
method that would be ethically very unacceptable in the European
Union (by ‘‘having their eyes removed and blood drained’’, Ma
et al. 2012), and the latter would almost certainly lead to major
artefacts in the liver histology during blood loss, such as collapse
of the hepatic sinus. In the present study (Figure 4), OC-Fe3O4
NPs caused a dose-dependent lipidosis with some diffuse necrosis
of the liver cells by day 1 and a concomitant increase in sinusoid
space. This is most easily explained by oxidative stress associated
with Fe exposure, and notably the nano form of Fe used here
caused remarkably similar pathology to excess dietary iron
sulphate. For example, Carriquiriborde et al. (2004) also showed
aspects of fatty change with loss of glycogen and an increase in
sinusoid space (also observed here, Figure 4). This suggests that
either some dissolved Fe from the NP form or Fe NPs themselves
were bioavailable to the liver cells or, more likely, that both forms
of Fe cause liver injury via oxidative stress. Iversen et al. (2013)
reported that magnetic resonance imaging and transmission
electron microscopy showed accumulation of polyacrylic acid-
coated g-Fe2O3 NPs in liver cells 1 h after i.v. infusion of the NPs
in mice, thus demonstrating that liver cells can take up intact Fe
particles. In the present study, the recovery time of the liver in
relation to the time course of GST also supports the latter
hypothesis of oxidative injury, where improvement in the liver
tissue mostly occurred after the increase in GST at week 1.
Conclusions and clinical perspectives
Overall, the data reported in the present study suggest that the
liver likely retains functional integrity with sub-lethal doses of
OC-Fe3O4 NPs, albeit with some stimulation of redox defences
and evidence of some tissue injury shortly after the injection. The
absence of changes in liver cholesterol and triacylglycerol
concentrations also support the notion of limited toxic effects.
One of the potential clinical applications of Fe3O4 NPs is for
enhancing nuclear magnetic resonance imaging (Kim et al. 2001)
and like all new medicines or medical devices, a weight of
evidence is needed to confirm that such Fe NPs are both safe and
effective in animal models before progressing to clinical trials
with human volunteers. The data so far (Sebekova et al. 2014,
Iversen et al. 2013) suggest no lasting adverse effects on modest
single injections of Fe3O4 NPs, and the subtle effects observed
here should not be a barrier to further investigations on the
medical applications of Fe NPs. For a prospective medicine, it is
also important that ineffective or unsafe candidates are removed
early on in the preclinical phase of drug development. This
requires a battery of in vitro and in silico assays, and in keeping
with the aims of the NanoTEST project, the data here, also
provides some in vivo observations to support the interpretation of
these alternative methods.
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